apple inc (AAPL:NASDAQ GS)

Executive Profile*

Background*

Dr. Arthur D. Levinson, Art, Ph.D. served as the President of Genentech Inc., since July 1995. Dr. Levinson served as the Chief Executive Officer of Genentech Inc. from July 1995 to April 2009. Dr. Levinson joined Google Inc., in 1980 as a Senior Scientist and held the position of Staff Scientist and Director of the Department of Cell Genetics at Genentech. Prior to 1999, he held various executive positions at Genentech Inc., including Vice President of Research Technology ... since April 1989, Vice President of Research since May 1990 and Senior Vice President of Research and Development from 1993 to 1995. He has been a Member of Genentech's Executive Management Team since 1990. He has been the Chairman of Genentech Inc. since September 1999 and also Apple Inc. since November 15, 2011. He served as Co-Lead Director of Apple Inc. and has been its Director since 2000. He has been Lead Director at Amyris, Inc. since March 2011. He has been a Director of Genentech Inc. since July 1995, Roche Holding AG since 2010 and Amyris, Inc. since April 2010. He has been a Director at NGM Biopharmaceuticals, Inc. since October 2009. He serves as a Director of Broad Institute of MIT and Harvard. He served as a Director of Google Inc., from April 2004 to October 2009. He is a Member of the Executive Committee and Genentech Inc.'s Cell Genetics Department since 1980. During his career, he has served on the editorial boards of “Molecular Biology and Medicine” and “Molecular and Cellular Biology,” and "Virology" as well as on the boards of the Pharmaceutical Research and Manufacturers of America, the Biotechnology Industry Organization, and the California Healthcare Institute. Dr. Levinson is active in the American Society of Microbiology, the New York Academy of Sciences, the American Association for the Advancement of Science and the American Society for Biochemistry and Molecular Biology. He sits on the board of Scientific Consultants for the Memorial Sloan-Kettering Cancer Center and is a Member of the Advisory Councils for the California Institute for Quantitative Biomedical Research (QB3), the Princeton University Department of Molecular Biology, and the Lewis-Sigler Institute for Integrative Genomics, also at Princeton. In addition, Dr. Levinson has authored or co-authored more than 80 scientific articles. Dr. Levinson received the Irvington Institute's 1999 Corporate Leadership Award in Science and was honored in the same year with the Corporate Leadership Award from the National Breast Cancer Coalition. He was inducted into the Biotech Hall of Fame at the 2003 Biotech Meeting of chief executive officers. Business Week named, Dr. Levinson one of the Best Managers of the Year in 2004 and 2005, and Institutional Investor named him America's Best Chief Executive Officer in the biotech category four years in a row from 2004 to 2007). In 2006, Princeton University awarded, Dr. Levinson the James Madison Medal for a distinguished career in scientific research and in biotechnology. Also in 2006, Barron's recognized him as one of "The World's Most Respected Chief Executive Officers," and the Best Practice Institute placed Dr. Levinson on their "25 Top Chief Executive Officers" list. From 1977 to 1980, he served as a Postdoctoral Fellow in the Department of Microbiology at the University of California, San Francisco. In 1977, Dr. Levinson holds a Ph.D. in Biochemistry from Princeton University and a Bachelor of Science degree in Molecular Biology from the University of Washington.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
AAPL:US	$433.26 USD	-1.32

COMPETITOR COMPENSATION